Evidence map›Paper›PMID 25391904›Full record

ArticleEMBO reports2014

Closing the MCM cycle at replication termination sites.

Armelle Lengronne, Philippe Pasero

Abstract readComment
In one paragraph

Article in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.Advances in experimental medicine and biology · 2017
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Armelle LengronneInstitute of Human Genetics CNRS, Montpellier, France.
Philippe PaseroInstitute of Human Genetics CNRS, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The initiation of eukaryotic DNA replication is a highly regulated process conserved from yeast to human. The past decade has seen significant advances in understanding how the CMG (Cdc45‐MCM‐GINS) replicative helicase is loaded onto DNA. However, very little was known on how this complex is removed from chromatin at the end of S phase. Two papers in a recent issue of Science [1], [2] show that in yeast and in Xenopus, the CMG complex is unloaded at replication termination sites by an active mechanism involving the polyubiquitylation of Mcm7.

Indexed as

DNA ReplicationUbiquitinationAdenosine TriphosphatasesAnimalsCell Cycle ProteinsDNA-Binding ProteinsF-Box ProteinsMinichromosome Maintenance Complex Component 7Minichromosome Maintenance ProteinsNuclear ProteinsRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinUbiquitin-Protein LigasesAdenosine TriphosphatasesCell Cycle ProteinsDNA-Binding ProteinsF-Box ProteinsMinichromosome Maintenance Complex Component 7Minichromosome Maintenance ProteinsNuclear ProteinsRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearSaccharomyces cerevisiae ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID25391904
PMCPMC4264923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.